AFB (TB) – Antibiogram for MTb Complex – Amikacin Drug by MGIT – Pure Growth of MTB Complex

This test determines the susceptibility of the MTb complex to the drug amikacin.

• This test is primarily done to determine the drug susceptibility of MTb complex to amikacin. • Selecting appropriate medications for treating TB • Assessing the effectiveness of specific antibiotics • Preventing the development of drug resistance • Optimising treatment outcomes

• When a patient is diagnosed with TB and requires guidance on which medications to use. • When TB treatment is not yielding the desired results. • When a patient has a history of contact with someone infected with drug-resistant TB. • When a patient's clinical condition worsens despite receiving TB treatment.

Abnormal results may suggest resistance to amikacin, which means alternative drugs need to be considered for treating TB.

• Discuss any medications you are taking with your doctor, as some may interfere with the test results. • Please reach out to your healthcare provider for any specific requirements.

Other tests that may be ordered alongside this test include: • MTb complex identification using molecular methods • Drug susceptibility testing for other TB medications

Amikacin Susceptibility Test, MGIT-based Amikacin Drug Susceptibility Testing

Tuberculosis (TB) is an infectious disease caused by the Mycobacterium tuberculosis bacteria. It primarily affects the lungs, but can also impact other organs. TB spreads through the air when an infected person coughs or sneezes. Symptoms include persistent cough, weight loss, fever, and fatigue. Early diagnosis and treatment are crucial to prevent complications and transmission.